In the world of compounding pharmacies, Novo Nordisk ended its collaboration with Hims and Hers over illegal mass compounding and deceptive marketing. This begs the question, what role are generics and compound pharmacies playing in the future GLP-1 space and is the $100 billion-plus market large enough for everyone
Unlike SGLT-2 inhibitors, semaglutide does not affect urinary glucose levels or create conditions that promote bacterial growth in the urinary tract
These typically improve over time as your body adjusts
J Biol Chem 267(11):74027405 Schirra J, Sturm K, Leicht P, Arnold R, Goke B, Katschinski M (1998) Exendin(939)amide is an antagonist of glucagon-like peptide-1(736)amide in humans
However, if your goal is significant weight loss, Wegovy is typically more effective